German biotech BioNTech today announced that the US Food and Drug Administration (FDA) has granted fast track designation to ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) has announced results for fourth-quarter and full-year 2025. Fourth-quarter ...

US drugmaker Bristol Myers Squibb (NYSE: BMY) says England, Wales and Northern Ireland are set to offer Opdivo (nivolumab) ...

The European Commission (EC) has granted marketing authorization for Dawnzera (donidalorsen) for the routine prevention of ...

Californian biopharma Corvus Pharmaceuticals has announced positive results from cohort four of the randomized, blinded, ...

France-based ErVimmune, a biotech developing therapeutic vaccines targeting new families of unconventional tumor antigens ...

Angelini Pharma, part of the privately owned Italian industrial group Angelini Industries, has announced the appointment of ...

A recent research study, conducted by Shi and colleagues and published in the Clinical Journal of the American Society of ...

Congressional negotiators released a more than 1,000 page bipartisan government funding bill on Tuesday, racing a shutdown ...

San Diego, USA-based ViroMissile has announced the appointment of Michael Wood as chief business officer (CBO). In this role, ...

The US Food and Drug Administration (FDA) yesterday issued a draft guidance for industry that provides recommendations to ...

Shares of US biotech Novavax were up 9% at $8.72 by midday on Tuesday, after it revealed it has entered into a license ...